Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1979-2-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0312-5963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-61
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:719983-Digoxin,
pubmed-meshheading:719983-Half-Life,
pubmed-meshheading:719983-Heart Failure,
pubmed-meshheading:719983-Humans,
pubmed-meshheading:719983-Infant,
pubmed-meshheading:719983-Infant, Newborn,
pubmed-meshheading:719983-Infant, Newborn, Diseases,
pubmed-meshheading:719983-Kinetics
|
pubmed:articleTitle |
Digoxin dosage schedules for neonates and infants based on pharmacokinetic considerations.
|
pubmed:publicationType |
Journal Article
|